These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 13608345)

  • 21. [A case of dermatomyositis associated with prostatic carcinoma: a case report].
    Sekine Y; Kubota Y; Kurihara J
    Hinyokika Kiyo; 2004 Feb; 50(2):95-7. PubMed ID: 15101164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate carcinoma: atrophy or not atrophy that is the question.
    Mikuz G; Algaba F; Beltran AL; Montironi R
    Eur Urol; 2007 Nov; 52(5):1293-6. PubMed ID: 17761384
    [No Abstract]   [Full Text] [Related]  

  • 23. Highly specific detection of prostate-specific antigen-positive cells in the blood of patients with prostate cancer or benign prostatic hyperplasia, using a real-time reverse-transcription-polymerase chain reaction method with improved sensitivity.
    Barbero G; Destefanis P; Procida S; Mandili G; Ulliers D; Ceruti C; Fiori C; Maule MM; Fontana D; Giribaldi G; Turrini F
    BJU Int; 2008 Dec; 102(11):1566-72. PubMed ID: 18549428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer.
    Davis JW; Nakanishi H; Kumar VS; Bhadkamkar VA; McCormack R; Fritsche HA; Handy B; Gornet T; Babaian RJ
    J Urol; 2008 Jun; 179(6):2187-91; discussion 2191. PubMed ID: 18423725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2009 Mar; 181(3):1091-7. PubMed ID: 19150091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of free to total prostate specific antigen ratio in serum in the diagnosis of prostatic enlargement.
    Bhuiyan AK; Kibria SA; Subhan SS
    Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):51-9. PubMed ID: 15813483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate.
    Kumar SM
    J Urol; 2005 Feb; 173(2):511-3. PubMed ID: 15643231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Canine prostate carcinomas express markers of urothelial and prostatic differentiation.
    LeRoy BE; Nadella MV; Toribio RE; Leav I; Rosol TJ
    Vet Pathol; 2004 Mar; 41(2):131-40. PubMed ID: 15017026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed metastatic renal carcinoma to prostate.
    Rodriguez A; Kang L; Politis C; Wade M; Sexton WJ; Miranda-Sousa A; Pow-Sang JM
    Urology; 2006 Mar; 67(3):623.e7-10. PubMed ID: 16527593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells.
    Berezovskaya O; Schimmer AD; Glinskii AB; Pinilla C; Hoffman RM; Reed JC; Glinsky GV
    Cancer Res; 2005 Mar; 65(6):2378-86. PubMed ID: 15781653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
    Rekhi B; Jaswal TS; Arora B
    Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case report: mucinous carcinoma of prostate].
    Noma M; Mori N; Kobayashi Y; Hara T; Yamaguchi S
    Hinyokika Kiyo; 2003 Oct; 49(10):591-3. PubMed ID: 14655602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of alpha1-antichymotrypsin (ACT) in prostatic carcinoma].
    Karseladze AI; Rytin IE; Matveev VB
    Arkh Patol; 2005; 67(1):30-3. PubMed ID: 15822791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate.
    Dema A; Tudose N
    Rom J Morphol Embryol; 1998; 44(1-4):93-100. PubMed ID: 15678849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review.
    Saad M; Abdel-Rahim M; Abol-Enein H; Ghoneim MA
    BJU Int; 2008 Dec; 102(11):1544-50. PubMed ID: 18565169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basaloid carcinoma of the prostate gland. An unusual finding.
    Parada DD; López CA; Moreira O
    Arch Esp Urol; 2004 Jun; 57(5):573-8. PubMed ID: 15382579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytogenetic changes and loss of heterozygosity in atypical adenomatous hyperplasia, in carcinoma of the prostate and in non-neoplastic prostate tissue using comparative genomic hybridization and multiplex-PCR.
    Bettendorf O; Schmidt H; Eltze E; Gockel I; Semjonow A; Bürger H; Böcker W; Brandt B
    Int J Oncol; 2005 Jan; 26(1):267-74. PubMed ID: 15586249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of serum protein-bound sialic acid in benign and malignant prostatic growth: possible role of oxidative stress in sialic acid homeostasis.
    Goswami K; Nandeesha H; Koner BC; Nandakumar DN
    Prostate Cancer Prostatic Dis; 2007; 10(4):356-9. PubMed ID: 17404581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognosis and predictive factors in prostate cancer].
    Albiges-Sauvin L; Lévy A; Massard C; Fizazi K
    Bull Cancer; 2009 Apr; 96(4):439-49. PubMed ID: 19357018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.